Two truncating PMS2 variants, c.2007-2A>G and c.2117del, were exclusively associated with a highly penetrant phenotype in our cohort, with brain tumors as the main clinical presentation occurring before the age of 10. This evidence concerns the gene PMS2 and brain neoplasm.